What Is PetMed Express, Inc. (PETS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, PetMed Express, Inc.'s intrinsic value is estimated at a composite fair value of $2.15. Trading at $1.95, the stock is approaching fair value or slight overvaluation (implied return of +10.1%), as 5 of 8 models suggest limited further upside. Notably, CUCE sees the most upside at +335.6% (fair value: $8.49), while Markov DDM is the most conservative at -99.0% ($0.02). The spread between these extremes — +434.6% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About PETS?
8 of 13 models are currently active for PETS. Of these, 3 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates PETS's intrinsic value at $1.02, implying -47.6% downside from the current price. See which stocks rank higher →
How Does PETS Rank in Retail-Drug Stores and Proprietary Stores?
Among 5 Retail-Drug Stores and Proprietary Stores stocks, PETS ranks #4 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.
PetMed Express, Inc.'s positioning within the Retail-Drug Stores and Proprietary Stores segment means that biosimilar competition timeline plays an outsized role in fundamental analysis. The sector's unique characteristics — including therapeutic area leadership — shape both the opportunity set and risk profile.
Is PETS a Value Trap?
CirclFi's Value Trap algorithm assigns PETS a score of 44/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
8 of 13 models are active for PetMed Express, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, PetMed Express, Inc. earns a quality score of 6.1/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.
The gap between the most bullish and bearish model spans +434.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every PETS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across PETS's 8 active models, average confidence is 20%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad